Clinical aspects of altered glycosylation of glycoproteins in cancer

Alteration of the expression of carbohydrate structures is frequently observed in tumor cells. This review summarizes the different changes of O‐ and N‐linked glycoproteins observed in cancer cells, the impact of the tumor‐related carbohydrate phenotypes on the clinical outcome of the cancer disease...

Full description

Saved in:
Bibliographic Details
Published inElectrophoresis Vol. 20; no. 2; pp. 362 - 371
Main Authors Orntoft, Torben F., Vestergaard, Else Marie
Format Journal Article
LanguageEnglish
Published Hoboken Wiley Subscription Services, Inc., A Wiley Company 01.02.1999
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Alteration of the expression of carbohydrate structures is frequently observed in tumor cells. This review summarizes the different changes of O‐ and N‐linked glycoproteins observed in cancer cells, the impact of the tumor‐related carbohydrate phenotypes on the clinical outcome of the cancer disease, and the various ways in which carbohydrate structures can interact with different carbohydrate‐detecting adhesion molecules, selectins, and sialoadhesins. Various ways of inhibiting the formation of cell adhesion‐engaged carbohydrates on the cell surface, or inhibiting the binding are discussed. Carbohydrate structures which are in clinical use as circulating tumor markers and the effect of genotypes on tumor marker concentrations are reviewed.
Bibliography:ArticleID:ELPS362
ark:/67375/WNG-K8DZ3XH1-P
istex:F8C80C31DE0FED967E63E5C28F411FB7F1B096DE
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ISSN:0173-0835
1522-2683
DOI:10.1002/(SICI)1522-2683(19990201)20:2<362::AID-ELPS362>3.0.CO;2-V